Items where Author is "Hamshaw, Isabel"

Article

Hamshaw, Isabel ORCID: https://orcid.org/0000-0001-6445-0738, Cominetti, Marco, Nana-Akyin, Princess, Ho Yee Ho, Ernie, Searcey, Mark ORCID: https://orcid.org/0000-0003-2273-8949 and Mueller, Anja ORCID: https://orcid.org/0000-0003-0774-0434 (2024) IS4-FAM, a fluorescent tool to study CXCR4 affinity and competitive antagonism in native cancer cells. Pharmacology Research and Perspectives, 12 (5). ISSN 2052-1707

Hamshaw, Isabel ORCID: https://orcid.org/0000-0001-6445-0738, Ellahouny, Youssef, Malusickis, Artur, Newman, Lia, Ortiz-Jacobs, Dante and Mueller, Anja ORCID: https://orcid.org/0000-0003-0774-0434 (2024) The role of PKC and PKD in CXCL12 and CXCL13 directed malignant melanoma and acute monocytic leukemic cancer cell migration. Cellular Signalling, 113. ISSN 0898-6568

Hamshaw, Isabel ORCID: https://orcid.org/0000-0001-6445-0738, Straube, Anne, Stark, Richard, Baxter, Laura, Alam, Mohammad T., Wever, Walter J., Yin, Jun, Yue, Yong, Pinton, Philippe, Sen, Aritro, Ferguson, Gregory D. and Blanks, Andrew M. (2023) PGF2α induces a pro-labour phenotypical switch in human myometrial cells that can be inhibited with PGF2α receptor antagonists. Frontiers in Pharmacology, 14. ISSN 1663-9812

Hamshaw, Isabel ORCID: https://orcid.org/0000-0001-6445-0738, Cominetti, Marco M. D., Lai, Wing-Yee, Searcey, Mark ORCID: https://orcid.org/0000-0003-2273-8949 and Mueller, Anja ORCID: https://orcid.org/0000-0003-0774-0434 (2023) The development of potent, competitive CXCR4 antagonists for the prevention of cancer metastasis. Biochemical Pharmacology, 218. ISSN 0006-2952

Hamshaw, Isabel ORCID: https://orcid.org/0000-0001-6445-0738, Ajdarirad, Morvarid and Mueller, Anja ORCID: https://orcid.org/0000-0003-0774-0434 (2019) The role of PKC and PKD in CXCL12 directed prostate cancer migration. Biochemical and Biophysical Research Communications, 519 (1). pp. 86-92. ISSN 0006-291X

Conference or Workshop Item

Hamshaw, Isabel ORCID: https://orcid.org/0000-0001-6445-0738 (2023) The role of PGF2α in the development of labour and how FP antagonists could prevent preterm birth. In: UNSPECIFIED.